Correlation Between Aravive and Akero Therapeutics
Can any of the company-specific risk be diversified away by investing in both Aravive and Akero Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aravive and Akero Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aravive and Akero Therapeutics, you can compare the effects of market volatilities on Aravive and Akero Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aravive with a short position of Akero Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aravive and Akero Therapeutics.
Diversification Opportunities for Aravive and Akero Therapeutics
-0.24 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Aravive and Akero is -0.24. Overlapping area represents the amount of risk that can be diversified away by holding Aravive and Akero Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Akero Therapeutics and Aravive is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aravive are associated (or correlated) with Akero Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Akero Therapeutics has no effect on the direction of Aravive i.e., Aravive and Akero Therapeutics go up and down completely randomly.
Pair Corralation between Aravive and Akero Therapeutics
Given the investment horizon of 90 days Aravive is expected to under-perform the Akero Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Aravive is 1.05 times less risky than Akero Therapeutics. The stock trades about -0.83 of its potential returns per unit of risk. The Akero Therapeutics is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest 4,420 in Akero Therapeutics on September 12, 2024 and sell it today you would lose (1,356) from holding Akero Therapeutics or give up 30.68% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 1.14% |
| Values | Daily Returns |
Aravive vs. Akero Therapeutics
Performance |
| Timeline |
| Aravive |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Akero Therapeutics |
Aravive and Akero Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Aravive and Akero Therapeutics
The main advantage of trading using opposite Aravive and Akero Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aravive position performs unexpectedly, Akero Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Akero Therapeutics will offset losses from the drop in Akero Therapeutics' long position.The idea behind Aravive and Akero Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.| Akero Therapeutics vs. Terns Pharmaceuticals | Akero Therapeutics vs. Madrigal Pharmaceuticals | Akero Therapeutics vs. Inozyme Pharma | Akero Therapeutics vs. Viking Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Other Complementary Tools
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |